Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nanexa | NANEXA | 17. mai 2024 | 0.94 | +7.27 |
NanoCap Group B | NANOCB | 17. mai 2024 | 8.70 | +0.69 |
Nanoform Finland | NANOFS | 17. mai 2024 | 24.00 | +2.56 |
Nanologica | NICA | 17. mai 2024 | 6.42 | 0.00 |
NASDAQ OMX Small Cap Sweden GI | NOMXSCSEGI | 17. mai 2024 | 4 437.69 | +0.08 |
NASDAQ OMX Small Cap Sweden PI | NOMXSCSE | 17. mai 2024 | 2 759.00 | +0.04 |
Nattaro Labs | NATTA | 17. mai 2024 | 0.54 | -0.92 |
Navigo Invest AB | NAVIGOSTAM | 17. mai 2024 | 4.33 | -2.48 |
Navigo Invest Pref | NAVIGOPREF | 17. mai 2024 | 108.00 | 0.00 |
NAXS | NAXS | 17. mai 2024 | 64.00 | 0.00 |
NCAB Group | NCAB | 17. mai 2024 | 79.60 | -0.38 |
NCC A | NCCA | 17. mai 2024 | 136.50 | 0.00 |
NCC B | NCCB | 17. mai 2024 | 136.10 | +1.04 |
Nederman Holding | NMAN | 17. mai 2024 | 221.50 | -0.23 |
NEL | NELO | 17. mai 2024 | 5.89 | 0.00 |
Nelly Group | NELLY | 17. mai 2024 | 16.98 | 0.00 |
Neobo Fastigheter | NEOBO | 17. mai 2024 | 18.16 | -1.30 |
NeoDynamics | NEOD | 17. mai 2024 | 1.00 | 0.00 |
Neola Medical | NEOLA | 17. mai 2024 | 2.04 | 0.00 |
Nepa | NEPA | 17. mai 2024 | 26.50 | +3.11 |
Net Insight B | NETIB | 17. mai 2024 | 5.37 | +1.32 |
Netel | NETEL | 17. mai 2024 | 14.76 | -0.94 |
NetJobs Group | NJOB | 17. mai 2024 | 0.33 | -1.81 |
New Nordic Healthbrands | NNH | 17. mai 2024 | 18.70 | 0.00 |
New Wave B | NEWAB | 17. mai 2024 | 112.40 | +3.26 |
Newbury Pharmaceuticals | NEWBRY | 17. mai 2024 | 3.10 | -0.64 |
News55 | N55 | 17. mai 2024 | 2.52 | 0.00 |
Nexam Chemical Holding | NEXAM | 17. mai 2024 | 3.01 | +0.33 |
Nexar Group | NXAR | 17. mai 2024 | 0.30 | +30.43 |
NextCell Pharma AB | NXTCL | 17. mai 2024 | 1.28 | -0.78 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.